Pulmonx Corp (LUNG) Reports Solid Revenue Growth Amidst Increased Operating Expenses

Year-Over-Year Revenue Climbs 28% in 2023, Gross Margin Remains Strong

Related Keywords

,Pulmonx Corp ,Financial Performance ,Zephyr Valve ,Medical Devices ,Balance Sheet ,Operating Expenses ,Revenue Growth ,Gross Margin ,International Revenue ,Gross Margins ,